المؤلفون: Massaro F., Pavone V., Stefani P. M., Botto B., Pulsoni A., Patti C., Cantonetti M., Visentin A., Scalzulli P. R., Rossi A., Galimberti S., Cimminiello M., Gini G., Musso M., Sorio M., Arcari A., Zilioli V. R., Luppi M., Mannina D., Fabbri A., Pietrantuono G., Annibali O., Tafuri A., Prete E., Mule A., Barbolini E., Marcheselli L., Luminari S., Merli F.

المساهمون: Massaro, F., Pavone, V., Stefani, P. M., Botto, B., Pulsoni, A., Patti, C., Cantonetti, M., Visentin, A., Scalzulli, P. R., Rossi, A., Galimberti, S., Cimminiello, M., Gini, G., Musso, M., Sorio, M., Arcari, A., Zilioli, V. R., Luppi, M., Mannina, D., Fabbri, A., Pietrantuono, G., Annibali, O., Tafuri, A., Prete, E., Mule, A., Barbolini, E., Marcheselli, L., Luminari, S., Merli, F.

مصطلحات موضوعية: AETHERA trial, autologous stem cell transplantation, brentuximab vedotin, hodgkin lymphoma, Adolescent, Adult, Aged, Antineoplastic Agents, Immunological, Combined Modality Therapy, Female, Follow-Up Studie, Hematopoietic Stem Cell Transplantation, Hodgkin Disease, Human, Male, Middle Aged, Prognosi, Retrospective Studie, Survival Rate, Young Adult

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34694649; info:eu-repo/semantics/altIdentifier/wos/WOS:000713467600001; volume:40; issue:1; firstpage:31; lastpage:39; numberofpages:9; journal:HEMATOLOGICAL ONCOLOGY; http://hdl.handle.net/11380/1269519Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85118336432

الإتاحة: https://doi.org/10.1002/hon.2939Test
http://hdl.handle.net/11380/1269519Test

المؤلفون: Castagnetti, F, Gugliotta, G., Breccia, M., Stagno, F., Iurlo, A., Albano, F., Abruzzese, E., Martino, B., Levato, L., Intermesoli, T., Pregno, P., Rossi, G., Gherlinzoni, F., Leoni, P., Cavazzini, F., Venturi, C., Soverini, S., Testoni, N., Alimena, G., Cavo, M., Martinelli, G., Pane, F., Saglio, G., Rosti, G., Baccarani, M., on behalf of the GIMEMA CML Working Party (Lucarelli, G., Polimeno, G., Ladetto, M., Pini, M., Rupoli, S., Scortechini, A. R., Galieni, P., Bigazzi, C., Cantore, N., Palmieri, F., Specchia, G., Russo, Rossi., Rambaldi, A., Ferrari, M. L., Palandri, F., Luatti, S., Iacobucci, I., Bochicchio, M. T., Apolinari, M., Fogli, M., Cervello, I., Capucci, A., Giuliani, G., Malpignano, A., Girasoli, M., Angelucci, E., Usala, E., De Biasi, E., Tagariello, G., Sartori, R., Di Raimondo, F., Vigneri, P., Molica, S., Lentini, M., Lanza, F., Viganò, C., Grasso, M., Rapezzi, D., Cuneo, A., Ciccone, M., Bosi, A., Gozzini, A., Gobbi, M., Pierri, I., Chianese, R., De Blasio, A., Ciccone, F., Capochiani, E., Pelosini, M., Musolino, C., Russo, S., Cortelezzi, A., Luppi, M., Marasca, R., Pogliani, E. M., Gambacorti-Passerini, C., Luciano, L., Izzo, B., Ferrara, F., Annunziata, M., Mettivier, V., Sessa, U., Latte, G., Noli, D., Rege-Cambrin, G., Fava, C., Semenzato, G., Binotto, G., Fabbiano, F., Turri, D., Siragusa, S., Caracciolo, C., Musso, M., Porretto, F., Cazzola, M., Orlandi, E., Falini, B., Falzetti, F., Visani, G., Isidor, I., Di Bartolomeo, P., Di Lorenzo, R., Vallisa, D., Trabacch, I., Pizzuti, M., Zuffa, E., Salvucci, M., Ronco, F., Lelo, D., Merli, F., Avanzini, P., Tosi, P., Merli, A., Sica, S., Sorà, F., Latagliata, R., De Fabritiis, P., Trawiska, M., Amadori, S., Cantonetti, M., Majolino, I., Pacilli, L., Ronci, B., Cedrone, M., Mengarelli, A., Romano, A., Tafuri, A., Montefusc, O., Iuliano, F., Infusino, S., Dore, F., Fozza, C., Bocchia, M., Defina, M., Liberati, Am., Luzi, D., Boccadoro, M., Ferrero, D., Vitolo, U., Nicolosi, M., Gottardi, M., Calistri, E., Fanin, R., Tiribelli, M., Pizzolo, G., Bonifacio, M., Rodeghiero, F., Di Bona, E. ).

المساهمون: Castagnetti, F, Gugliotta, G., Breccia, M., Stagno, F., Iurlo, A., Albano, F., Abruzzese, E., Martino, B., Levato, L., Intermesoli, T., Pregno, P., Rossi, G., Gherlinzoni, F., Leoni, P., Cavazzini, F., Venturi, C., Soverini, S., Testoni, N., Alimena, G., Cavo, M., Martinelli, G., Pane, F., Saglio, G., Rosti, G., Baccarani, M., and on behalf of the GIMEMA CML Working Party [, Palandri F.], Pane, Fabrizio, Gugliotta, G, Breccia, M, Stagno, F, Iurlo, A, Albano, F, Abruzzese, E, Martino, B, Levato, L, Intermesoli, T, Pregno, P, Rossi, G, Gherlinzoni, F, Leoni, P, Cavazzini, F, Venturi, C, Soverini, S, Testoni, N, Alimena, G, Cavo, M, Martinelli, G, Pane, F, Saglio, G, Rosti, G, Baccarani, M, GAMBACORTI PASSERINI, C

مصطلحات موضوعية: DIAGNOSED CHRONIC-PHASE, Oncology, Male, Cancer Research, Time Factors, bcr-abl, Fusion Proteins, bcr-abl, Antineoplastic Agent, Hematology, Anesthesiology and Pain Medicine, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, 80 and over, Cumulative incidence, Young adult, Chronic, Aged, 80 and over, Leukemia, PATIENTS RECEIVING IMATINIB, CHRONIC MYELOGENOUS LEUKEMIA, TYROSINE KINASE INHIBITORS, BCR-ABL1 TRANSCRIPT LEVELS, EARLY MOLECULAR RESPONSE, CML WORKING PARTY, 3-YEAR FOLLOW-UP, EUROPEAN LEUKEMIANET, 400 MG, Myeloid leukemia, Middle Aged, Prognosis, Treatment Outcome, Retreatment, Imatinib Mesylate, Female, Tyrosine kinase, Human, medicine.drug, Adult, medicine.medical_specialty, Time Factor, Adolescent, Prognosi, Protein Kinase Inhibitor, Socio-culturale, Antineoplastic Agents, Treatment results, Follow-Up Studie, Young Adult, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Internal medicine, medicine, Humans, Protein Kinase Inhibitors, Aged, Antineoplastic Combined Chemotherapy Protocol, business.industry, Fusion Proteins, Imatinib, Follow-Up Studies, Surgery, Imatinib mesylate, BCR-ABL Positive, business, Myelogenous

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9a3f6a783375013273256c71341e1c8Test
http://hdl.handle.net/11365/1002418Test

المؤلفون: Coiffier, B, Osmanov, E, Hong, X, Scheliga, A, Mayer, J, Offner, F, Rule, S, Teixeira, A, Walewski, J, de Vos, S, Crump, M, Shpilberg, O, Esseltine, D, Zhu, E, Enny, C, Theocharous, P, van de Velde, H, Elsayed, Y, Zinzani, P, Abdulkadyrov, K, Afanasiev, B, Aguayo Gonzalez, A, Andre, M, Belada, D, Ben Yehuda, D, Bezares, R, Biakhov, M, Bolam, S, Borbenyi, Z, Bron, D, Buckstein, R, Bumbea, H, Caballero Barrigon, M, Campos, L, Cantonetti, M, Capra Zanella, M, Christiansen, N, Cohen, G, Colita, N, Cosgriff, T, Culligan, D, Del Giglio, A, Dichmann, R, Dietzfelbinger, H, Digumarti, R, Dmoszynska, A, Domnikova, N, Dubinsky, P, Dunaev, Y, Easow, J, Eberwine, S, Economopoulos, T, Egyed, M, Ellerton, J, Eom, H, Farmer, L, Fenske, T, Fields, P, Fillet, G, Frank, R, Gaisarova, G, Garicochea, B, Gasztonyi, Z, Gavish, I, Gheorghita, E, Gladkov, O, Goldberg, V, Golenkov, A, Gomez Almaguer, D, Gonzalez Barca, E, Guan, Z, Gupta, S, Hellmann, A, Hermann, R, Honkanen, T, Hu, E, Huang, X, Hudecek, J, Illes, A, Intragumtornchai, T, Jedrzejczak, W, Jones, L, Jootar, S, Kahanic, S, Karamanesht, E, Ke, X, Khuageva, N, Kim, W, Kimby, E, Komisarenko, V, Kouroukis, T, Kuliczkowski, K, Kuzina, L, Kyselyova, M, Labanca, V, Lange, A, Le Gouill, S, Leahy, M, Liberati, A, Linden, O, Liu, T, Lubennikov, V, Lundin, J, Lysa, T, Lysenko, I, Lytvyn, I, Makhson, A, Manikhas, G, Masliak, Z, Mcintyre, R, Medvedeva, N, Mena, R, Merkulov, V, Mesters, R, Milpied, N, Min, Y, Moezi, M, Mohrbacher, A, Mollee, P, Morgan, D, Morschhauser, F, Mysanikov, A, Nagler, A, Nair, S, Naparstek, E, Nawarawong, W, Noga, S, Oliveira, I, Okada, C, Oriol Rocafiguera, A, Page, R, Papajik, T, Pasquini, R, Patel, M, Patel, R, Paton, E, Pavlov, V, Pospelova, T, Prasad, S, Pylypenko, H, Raposo, J, Rekhtman, G, Rivas, S, Robak, T, Saba, S, Salles, G, Saltzman, M, Samoilova, O, Samuels, B, Sanani, S, Sebban, C, Silva da Gomes, M, Shen, Z, Shi, Y, Shtalrid, M, Siritanaratkul, N, Skotnicki, A, Solal Celigny, P, Soubeyran, P, Spencer, A, Stevens, D, Suh, C, Sulek, K, Suvorov, A, Szer, J, Theunissen, K, To Bik, L, Tothova, E, Trneny, M, Van De Velde, A, Van Hoof, A, Van Steenweghen, S, Vanhatalo, S, Varma, S, Vidyasagar, M, Vilchevskaya, K, Vitolo, U, Wang, H, Warzocha, K, Wild, A, Zachee, P, Zanichelli, M, Zhang, W, Zoppegno, L, Zoumbos, N

المساهمون: Coiffier B., Osmanov E.A., Hong X., Scheliga A., Mayer J., Offner F., Rule S., Teixeira A., Walewski J., de Vos S., Crump M., Shpilberg O., Esseltine D.L., Zhu E., Enny C., Theocharous P., van de Velde H., Elsayed Y.A., Zinzani P.L., LYM-3001 study investigators

المصدر: The Lancet. Oncology. 12(8)

مصطلحات موضوعية: Oncology, Male, Lymphoma, Settore MED/06 - Oncologia Medica, Follicular lymphoma, Bortezomib, Antibodies, Monoclonal, Murine-Derived, 0302 clinical medicine, Maintenance therapy, Prednisone, immune system diseases, Recurrence, hemic and lymphatic diseases, Monoclonal, Antineoplastic Combined Chemotherapy Protocols, 80 and over, Lymphoma, Follicular, Multiple myeloma, Infusion Pumps, Aged, 80 and over, Middle Aged, Boronic Acids, 3. Good health, 030220 oncology & carcinogenesis, Pyrazines, Rituximab, Female, medicine.drug, Murine-Derived, Adult, medicine.medical_specialty, rituximab-naive, Antineoplastic Agents, Antibodies, Disease-Free Survival, 03 medical and health sciences, Young Adult, follicular lymphoma, Internal medicine, Neoplasm Staging, Humans, Aged, medicine, business.industry, Follicular, medicine.disease, Clinical trial, rituximab-sensitive, Immunology, business, Settore MED/15 - Malattie del Sangue, 030215 immunology

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a13b94128df5db75a9919f1ae0f67a71Test
https://pubmed.ncbi.nlm.nih.gov/21724461Test

المؤلفون: Postorino, M., Pupo, L., Provenzano, I., Principe, M., Buccisano, F., Franceschini, L., Rizzo, M., Nasso, D., Meconi, F., Onnis, I., Vaccarini, S., Zizzari, A., Anemona, L., Mauramati, S., Bruno, E., Cantonetti, M., Amadori, S., Del Principe, M I

المصدر: Annals of Hematology; Jan2016, Vol. 95 Issue 1, p153-154, 2p

مصطلحات موضوعية: T cells, MYCOSIS fungoides, CANCER chemotherapy, ALEMTUZUMAB, THERAPEUTICS, TUMORS, ANTINEOPLASTIC agents, DOXORUBICIN, ETOPOSIDE, MONOCLONAL antibodies, MOUTH tumors, SKIN tumors, VINCRISTINE, TREATMENT effectiveness, CYCLOPHOSPHAMIDE, PREDNISOLONE, DIAGNOSIS

المؤلفون: Pagano L., Criscuolo M., Galli E., Storti S., Fianchi L.

المساهمون: Pagano, Livio, Criscuolo, Marianna, Broccoli, A., Piciocchi, A., Varettoni, M., Galli, Eugenio, Anastasia, A., Cantonetti, M., Trentin, L., Kovalchuk, S., Orsucci, L., Frustaci, A., Spolzino, A., Volpetti, S., Annibali, O., Storti, Sergio, Stelitano, C., Marchesi, F., Offidani, M., Casadei, B., Nizzoli, M. E., De Luca, M. L., Fianchi, Luana, Motta, M., Guarnera, L., Simonetti, E., Visentin, A., Vassallo, F., Deodato, M., Sarlo, C., Olivieri, A., Falini, B., Pulsoni, A., Tiacci, E., Zinzani, P. L.

مصطلحات موضوعية: Adult, Aged, 80 and over, Cladribine, Follow-Up Studies, Humans, Middle Aged, Recurrence, Remission Induction, Retrospective Studies, Treatment Outcome, Young Adult, Antineoplastic Agents, Leukemia, Hairy Cell, Settore MED/15 - MALATTIE DEL SANGUE

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35853850; info:eu-repo/semantics/altIdentifier/wos/WOS:000827732900001; volume:12; issue:7; firstpage:109; lastpage:120; numberofpages:12; issueyear:2022; journal:BLOOD CANCER JOURNAL; https://hdl.handle.net/10807/223791Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85134416463

الإتاحة: https://doi.org/10.1038/s41408-022-00702-9Test
https://hdl.handle.net/10807/223791Test

المؤلفون: Livio Pagano, Marianna Criscuolo, Alessandro Broccoli, Alfonso Piciocchi, Marzia Varettoni, Eugenio Galli, Antonella Anastasia, Maria Cantonetti, Livio Trentin, Sofia Kovalchuk, Lorella Orsucci, Annamaria Frustaci, Angelica Spolzino, Stefano Volpetti, Ombretta Annibali, Sergio Storti, Caterina Stelitano, Francesco Marchesi, Massimo Offidani, Beatrice Casadei, Maria Elena Nizzoli, Maria Lucia De Luca, Luana Fianchi, Marina Motta, Luca Guarnera, Edoardo Simonetti, Andrea Visentin, Francesco Vassallo, Marina Deodato, Chiara Sarlo, Attilio Olivieri, Brunangelo Falini, Alessandro Pulsoni, Enrico Tiacci, Pier Luigi Zinzani

المساهمون: Pagano L., Criscuolo M., Broccoli A., Piciocchi A., Varettoni M., Galli E., Anastasia A., Cantonetti M., Trentin L., Kovalchuk S., Orsucci L., Frustaci A., Spolzino A., Volpetti S., Annibali O., Storti S., Stelitano C., Marchesi F., Offidani M., Casadei B., Nizzoli M.E., De Luca M.L., Fianchi L., Motta M., Guarnera L., Simonetti E., Visentin A., Vassallo F., Deodato M., Sarlo C., Olivieri A., Falini B., Pulsoni A., Tiacci E., Zinzani P.L.

مصطلحات موضوعية: Adult, Aged, 80 and over, Leukemia, Hairy Cell, Long-term follow-up,cladribine, hairy cell leukemia, Leukemia, Hairy Cell, Remission Induction, Antineoplastic Agents, Hematology, Middle Aged, Settore MED/15 - MALATTIE DEL SANGUE, Young Adult, Treatment Outcome, Oncology, Recurrence, 80 and over, Cladribine, Humans, Aged, Follow-Up Studies, Retrospective Studies

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c9ec2dbf70212b37e5d85a69625c145Test
https://hdl.handle.net/11585/904684Test

المؤلفون: Turriziani, M.¹, Caporaso, P.², Bonmassar, L.², Buccisano, F.³, Amadori, S.³, Venditti, A.³, Cantonetti, M.³, D’Atri, S.², Bonmassar, E.^4,5 bonmasse@yahoo.com

المصدر: Pharmacological Research. Apr2006, Vol. 53 Issue 4, p317-323. 7p.

مصطلحات موضوعية: *ANTINEOPLASTIC agents, *TRIAZENES, *ACUTE leukemia, *TRANSFERASES, *LEUKEMIA treatment